T. Rowe Price Associates’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $522K | Buy |
|
|||||
|
2025
Q4 | $430K | Buy |
|
|||||
|
2025
Q3 | $377K | Buy |
|
|||||
|
2025
Q2 | $237K | Buy |
|
|||||
|
2025
Q1 | $229K | Buy |
|
|||||
|
2024
Q4 | $185K | Buy |
|
|||||
|
2024
Q3 | $185K | Buy |
|
|||||
|
2024
Q2 | $138K | Buy |
|
|||||
|
2024
Q1 | $94K | Buy |
|
|||||
|
2023
Q4 | $75K | Buy |
|
|||||
|
2023
Q3 | $55K | Buy |
|
|||||
|
2023
Q2 | $59K | Buy |
|
|||||
|
2023
Q1 | $66K | Buy |
|
|||||
|
2022
Q4 | $47K | Buy |
|
|||||
|
2022
Q3 | $35K | Buy |
|
|||||
|
2022
Q2 | $27K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.7M | Buy |
|